FITX (CEN Biotech, Inc.) is shaping up very well for our followers, once again today, with mid-day gains of another 8.89%, as trading continues to pick up powerfully for this fast growing penny stock play. As we have stated in the past, FITX commands a share structure that is significantly larger than what we generally go for but due to a combination of incredible momentum, significant business accomplishments, and growing recognition among investors, we have chosen to label it as yet another prime marijuana penny stock play. Our Platinum Members have now seen profit potential of more than 4,800% over the course of the past month, on our winning penny stock picks and we believe that the duration of 2014, will see many more impressive power plays from our advertising platform. Though ENDO continues to be our main marijuana play, due to its low float allowing for swift movement, on comparatively little buying pressure, we believe that the ever-growing popularity of FITX, may allow for it to escape the pratfalls that are often found with regard to larger float plays, and continue to see some nice movement to the upside.
FITX has been forging some powerful alliances among other top penny stocks within the marijuana industry, so there is not telling how far it may be able to go, as they continue to progress and make further strides within the industry. It is pretty rare to see a play with this sort of share structure garner the sort of attention and popularity that this one has, among investors, so this will certainly be a play that you will want to continue to keep an eye on, as things progress.
Pennystockdream.com and its employees are not registered as Investment Adviser's in any jurisdiction whatsoever. We encourage all of those that are interested in any other form of investment, to conduct their own research to garner a better understanding of what they are getting involved in. Be sure to read the full disclaimer for this announcement here: http://www.pennystockdream.com/blog/full-disclaimer-for-fitx